[0042] In step 4), Alloc in Fmoc-Lys(Alloc)-OH is removed twice using 0.1-0.3 equivalents of Pd(PPh 3 ) 4 and 5-10 equivalents of morpholine or phenylsilane for 10-30 min each time, wherein CH 2 Cl 2 is used as a solvent in the removal
The decision to terminate the clinical development of Lotiglipron was based on the pharmacokinetic data from the clinical Phase 1 drug-drug interaction studies (NCT05671653 and NCT05788328), as well as the laboratory measurements of elevated transaminases in these Phase 1 studies and the ongoing Phase 2 study (NCT05579977)
Bjursell M, Admyre T, Goransson M, Marley AE, Smith DM, Oscarsson J, et al
Therefore, documentation of objective outcomes is critical to provide patients with information regarding actual changes in curvature and penile dimensions
As a trusted Tirzepatide Powder Bulk manufacturer, we specialize in OEM partnerships
Gut 69 (8), 14831491